Meeting Web banner

ROCK Home ROCK Home Past & Future Meetings Past & Future Meetings

2026 Annual Meeting Program

Friday, January 30, 2026
8:00 - 10:00
Executive Committee Meeting
10:00
Registration Open
10:30 - 10:45
Welcome from ROCK Society President
10:45 - 12:00
Poster session
Co-moderators: Kris Penniston, PhD, RD; Smita De, MD
(2 minute presentation, 2 minute discussion)

1. Characteristics of stone formers with stones composed of calcium phosphate with vs. without struvite
Peihsuan Tsai
University of Texas Southwestern

2. Dual Laser Lithotripsy: A New Concept for More Efficient Stone Fragmentation
Roshan Patel
University of California, Irvine

3. Genetic Liability to Urolithiasis and Risk of Autism Spectrum Disorder: A Two-Sample Mendelian Randomization Study
Ahmed Zaher
Mayo Clinic

4. Think in 3D for Stone Surgery: Volumetric Stone Burden Better Correlates with Operative Effort Than Linear Measurements
Benedikt Winzer
University of Rochester

5. Improvement in 24-hour urine parameters associates with decreased symptomatic kidney stone recurrence
Wilson Sui
University of Michigan

6. Ammonium acid urate stones
Megan Prochaska
University of Chicago

7. Seeing the Problem Clearly: Improving Stone Visualization in Ureteroscopy
Charan Mohan
Vanderbilt University

8. Identification of Novel Pharmacotherapies for Kidney Stone Prevention Utilizing Computational Algorithms and Modeling
Brian Dick
University of California, San Francisco

9. Clinical Correlates And Prognostic Value Of Agatston-Based Nephrocalcinosis Quantification In Primary Hyperoxaluria Type 1
Boxing Su
Mayo Clinic Rochester

10. Association of Stent-Associated Symptoms with Acceptability of Future Stent Placement: Results from STENTS
Nayan Shah
University of Washington Department of Urology

11. Perioperative Meditation to Improve Physical and Emotional Health After Ureteroscopy: A Pilot Randomized Controlled Trial
Madhumita Parmar
University of Pennsylvania

12. Extended Antibiotic Prophylaxis Mitigates Post-Stent Removal Infection in Urolithiasis Surgery
Justine Lam
University of Rochester

13. Do AI Chatbots provide accurate information on patient-oriented questions about nephrolithiasis
Smita De
Cleveland Clinic

14. Characterization of costs, discounts, and payment plans for patients seeking urologic appointments - a national cross-sectional study
Darren Chau
University of California, San Francisco

15. Understanding Sociodemographic Barriers to Electronic Patient-Reported Outcome Completion: Experience with the WISQOL
Carl Ceraolo
University of Rochester Medical Center

16. Assessing financial toxicity in Cystinuria: The impact of healthcare utilization and out-of-pocket spending
Jackson Cabo
Mayo Clinic Arizona

17. Stent vs No Stent in Ureteroscopy for Renal Stones
Seth Bechis
UCSD

18. Improving Laser Lithotripsy by 3D Real-Time Super-Resolution Cavitation Mapping
Junjie Yao
Duke University
12:00 - 1:00
Lunch SymposiaSupported by Karl Storz
Done & Dusted – How Suction Technology Changes Stone Treatment
Dr. Wilson Sui, MD
Clinical Assistant Professor of Urology
Medical School
1:15 - 2:15
Session One: Genetics of Stone Disease
Co-moderators: David Sas, DO, MPH; Naim Maalouf, MD
1:15 - 1:30
Monogenic calcium oxalate stone disorders in pet dogs and the opportunities they present
Eva Furrow
University of Minnesota
1:30 - 1:45
Contribution of rare gentic variants to urinary stone risk
John Lieske
Mayo Clinic
1:45 - 2:00
Genetics and The Alkaline Stone Former
Ryan Steinberg
University of Iowa Health Care
2:00 - 2:15
Genotyping characteristics of Medullary sponge kidney cohort
Abdulmueti Alshareef
Mayo Clinic
2:15 - 3:00
Session Two: Epidemiology of Stone Disease
Co-Moderators: John Hollingsworth, MD; Davis Viprakasit, MD
2:15 - 2:30
New and Rare Stone Constituents: Insights From a Cross-Disciplinary Discovery Pipeline
Sara Best
University of Wisconsin - Madison and Litholink
2:30 - 2:45
Impact of Urine Metabolic Profiles on Kidney Donor Eligibility in Candidates with Nephrolithiasis
Mira Keddis
Mayo Clinic
2:45 - 3:00
Screening and Registry Project for hereditary Urolithiasis Using Urine Mass spectrometry
Seiji Tanaka
Kurume University School of Medicine
3:00 - 3:30 pm
BREAK Visit Posters and Exhibits
3:30 - 4:00 pm
Session Three: Crystallization and Urinary Supersaturation
Co-moderators: John Asplin, MD; Vernon Pais, MD
3:30 - 3:45
Targeted Modulation of Brushite Crystallization for Kidney Stone Prevention
Muhammad Osman Khalid
University of Houston
3:45 - 4:00
Urinary supersaturation in a Randomized trial among Individuals with Nephrolithiasis comparing Empiric versus selective therapy (URINE)
Ryan Hsi
University of California, Irvine
4:00 - 5:15
Session Four: Patient Centered Stone Care and Health Outcomes
Co-moderators: Kyle Wood, MD; Allan Jhagroo, MD
4:00 - 4:30
Panel Discussion: How to Build Multidisciplinary Stone Team
Co-Moderators: Kyle Wood and Allan Jhagroo
Nephrology - Matthew Breeggeman
Geneticist - Wilfred Wu
Pediatric Nephrology - David Sas
Urology - Kymora Scotland
4:30 - 4:45
Patient perspectives on care delays for kidney stones
David Bayne
UCSF
4:45 - 5:00
Medicaid patients faced decreased access to care and increased appointment wait times for urologic nephrolithiasis care - a national cross-sectional study
Joy Barrett
University of California, San Francisco
5:00 - 5:15
Is Shared Decision-Making for Ureteral Stent Placement after Ureteroscopy Possible?
Juan Marcos Gonzalez/Chuck Scales
Duke University
5:15 - 5:30
Wrap Up and Announcements
5:30 - 6:30
NETWORKING RECEPTION IN EXHIBIT HALL

Saturday, January 31, 2026
7:30
Continental Breakfast with Exhibitors
8:00 - 9:00
Session Five: Mechanisms of Stone Formation
Co-moderators: Orson Moe, MD; Megan Prochaska, MD
8:00 - 8:15
Urinary extracellular vesicles from calcium oxalate kidney stone formers are enriched in bioactive lipids and cause mitochondrial dysfunction in mIMCD3 cells
Niharika Bala
University of Florida
8:15 - 8:30
Renal immune cells crosstalk in kidney stone pathogenesis
Muthuvel Jayachandran
Mayo Clinic College of Medicine and Science
8:30 - 8:45
Unbound Calcium and Elevated Urinary Iron: A Novel Mechanism Underlying Nephrolithiasis in Thalassemia
Marshall Stoller
University of California, San Francisco
8:45 - 9:00
Evolutionary and Comparative Physiological Considerations for Calculogenesis
Scott Wiener
SUNY Upstate Medical University
9:00 - 9:30
Session Six: State of the Art Lecture: Ultrastructure Understanding of Stone Formation
Moderator: Nicole Miller, MD
Sunita Ho
USCF
9:30 - 10:30
Session Seven: Randall's plaques and the renal papilla
Co-moderators: Matthew Lee, MD; James Lingeman, MD
9:30 - 9:45
Understanding of Randall's plaque in 2026: from histology to genomics
Kazumi Taguchi
University of Alabama at Birmingham
9:45 - 10:00
Transcriptomic Insights into Renal Papillary Mineralization in Cats
Nuttha Hengtrakul
University of Minnesota
10:00 - 10:15
Epithelial injury as the cause of ductal plugs, and why this is a more serious mineralization of the renal papilla in stone formers
James Williams
Indiana University
10:15 - 10:30
Zinc Enrichment and Organic-Inorganic Interplay in Human Renal Plaques and Stones
Benjamin Greenfield
Tufts University School of Medicine
10:30 - 11:00
BREAK Visit Posters and Exhibits
11:00 - 12:00
Session Eight: Oxalate metabolism and Hyperoxaluria
Co-moderators: John Knight, PhD; Sonia Fargue, MD
11:00 - 11:15
Production of oxalate by human microbiome associated microbes: Sequential in vitro to in vivo evidence
Aaron Miller
Cleveland Clinic
11:15 - 11:30
Tenapanor - A New Approach to Reducing Hyperoxaluria and Kidney Stone Risk?
Jonathan Whittamore
UT Southwestern Medical Center
11:30 - 11:45
Developing the Novel Sorbent ZO as an Effective Oral Gut Oxalate Binder: Therapeutic Implications for Hyperoxaluria, Hyperoxalemia, and Related Disorders
Hatim Hassan
Mayo Clinic-Rochester
11:45 - 12:00
Hyperoxaluria in Astronauts During Long-duration Spaceflight
Juliana Villanueva
Mass General Brigham
12:00 - 1:00 PM
Lunch Symposium – Supported by Boston Scientific
Title: The Future of Ureteroscopy
Moderator: Tom Chi, MD; University of Alabama Birmingham
Panelists:
Dan Wollin, MD; Mass General Brigham
Naveen Kachroo, MD; Henry Ford
Kevin Wymer, MD; Mayo Clinic – Rochester
Description: Urology is experiencing an unprecedented wave of technological innovation, particularly in enhancing ureteroscopy and stone treatment. This symposium brings together leading urologists to share their insights on how these advancements are transforming clinical practice. Attendees will gain a deeper understanding of the impact of specific technologies, their practical applications, and the future direction of urological care.
1:00 - 1:30 PM
Business Meeting
* Business Meeting for members only
1:30 - 2:30
Session Nine: Innovation in Surgical Management of Stones
Co-moderators: Michael Lipkin, MD; Jo Semins, MD
1:30 - 1:45
Development and Evaluation of Gaze-based Training for Endoscopic Kidney Stone Surgery
Nicholas Kavoussi
Vanderbilt University Medical Center
1:45 - 2:00
Burst wave lithotripsy and ultrasonic propulsion: recent advances in clinical applications
Claire Yang
University of Washington
2:00 - 2:15
Comparison of Stone Dusting, Fragmenting, and Thermal Injury Risk Produced by Ho:YAG Laser and TFL
Junqin Chen
Duke University
2:15 - 2:30
Nanofluid-Enhanced Laser Lithotripsy by NIR Absorber
Qingsong Fan
The University of Chicago
2:30 - 3:00
BREAK Visit Posters and Exhibits
3:00 - 4:15
Session Ten: Microbes and Stone Disease
Co-moderators: Peggy Pearle, MD, PhD; Vincent Bird, MD
3:00 - 3:15
Leveraging Microbial Metabolites to Reduce Calcium Oxalate Stone Risk Factors in Dogs
Emily Coffey
University of Minnesota
3:15 - 3:30
Microbial Transplant Therapy for Kidney stones: A novel, yet mixed bag
Joshua Stern
Intermountain Health
3:30 - 3:45
Development of an in vitro benchtop ureteroscopy model to estimate delivery of bacterial and inflammatory load
Stephen Hassig
University of Rochester Medical Center
3:45 - 4:00
The Treatment of Kidney Stones in the Context of Recurrent UTIs: a Report from the EDGE consortium
Connor Forbes
University of British Columbia
4:00 - 4:15
Uropathogenic Bacteria Trigger Calcium Oxalate Nephrolithiasis via Biofilm Formation
Kymora Scotland
University of California, Los Angeles (UCLA)
4:15 - 5:00 pm
Session Eleven: The Future of Stone Research
Co-moderators: Thomas Chi, MD; David Goldfarb, MD
4:15 - 4:30
Introducing the USDHub cohort as a publicly accessible database for the kidney stone research community
Gregory Tasian
Children's Hospital of Philadelphia
4:30 - 4:45
Federal Research Funding Threats and Opportunities - How can we safeguard the future of stone research?
Naveen Kachroo
Henry Ford Health
4:45 - 5:00
Discussion
5:00 - 5:15
Closing Comments
6:00 pm
Reception at the Bobby Hotel